Abeclib 150 MG (Abemaciclib) Tablets
Introduction Abeclib 150 mg (Abemaciclib) Tablet is a precision-driven CDK4/6 kinase inhibitor designed to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology innovation, and supplied globally by Onco Solution, this medication offers targeted therapy to delay disease progression and […]
Bigatab 90 MG (Brigatinib) Tablets
Introduction Bigatab 90 mg (Brigatinib) Tablet is a next-generation tyrosine kinase inhibitor (TKI) designed for ALK-positive and ROS1-positive non-small cell lung cancer (NSCLC). Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology therapeutics, and supplied globally by Onco Solution, this advanced medication targets resistant mutations to delay disease progression. With its unique ability to inhibit multiple kinases—including ALK, ROS1, […]
Capcitab 500 MG (Capecitabine) Tablet
Introduction Capcitab 500 mg (Capecitabine) Tablet is an oral chemotherapeutic agent designed to treat colorectal cancer, breast cancer, and gastric cancer. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology therapeutics, and supplied globally by Onco Solution, this medication offers a convenient and targeted approach to cancer treatment. As a prodrug of 5-fluorouracil (5-FU), Capcitab 500 mg (Capecitabine) Tablet […]
Capcitab 150 MG (Capecitabine) Tablets
Introduction Capcitab 150 mg (Capecitabine) Tablet is an oral chemotherapeutic agent designed to treat colorectal cancer, breast cancer, and gastric cancer. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology therapeutics, and supplied globally by Onco Solution, this lower-dose formulation offers precise dosing flexibility for tailored cancer treatment. As a prodrug of 5-fluorouracil (5-FU), Capcitab 150 mg (Capecitabine) Tablet […]
Exemis 25 MG (Exemestane) Tablets
Introduction Exemis 25 mg (Exemestane) Tablet is a steroidal aromatase inactivator specifically formulated for the treatment of hormone receptor-positive (HR+) breast cancer in postmenopausal women. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology therapeutics, and supplied globally by Onco Solution, this medication offers a potent and irreversible mechanism to suppress estrogen production, a key driver of tumor […]
Fenitab 200 MG (Sorafenib) Tablets
Introduction Fenitab 200 mg (Sorafenib) Tablet is an oral multikinase inhibitor designed to treat unresectable hepatocellular carcinoma (HCC) and advanced renal cell carcinoma (RCC). Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology therapeutics, and supplied globally by Onco Solution, this targeted therapy disrupts tumor growth and angiogenesis by inhibiting critical kinases involved in cancer progression. Fenitab 200 mg […]
Imitab 400 MG (Imatinib) Tablets
Introduction Imitab 400 mg (Imatinib) Tablet is a revolutionary tyrosine kinase inhibitor designed to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), gastrointestinal stromal tumors (GIST), and rare cancers like aggressive systemic mastocytosis (ASM) and dermatofibrosarcoma protuberans (DFSP). This targeted therapy disrupts cancer progression by inhibiting abnormal kinase activity, offering high efficacy with manageable side effects. Key Benefits & Mechanism […]
Lenor 2.5 MG (Letrozole) Tablets
Introduction Lenor 2.5 mg (Letrozole) Tablet is a nonsteroidal aromatase inhibitor designed for the first-line treatment of advanced or metastatic hormone receptor-positive breast cancer in postmenopausal women. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology therapeutics, and supplied globally by Onco Solution, this targeted therapy suppresses estrogen production to starve hormone-dependent tumors. Lenor 2.5 mg (Letrozole) Tablet […]
Osimatab 80 MG (Osimertinib) Tablet
Introduction Osimatab 80 mg (Osimertinib) Tablet is a groundbreaking third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) harboring specific EGFR mutations, including T790M, L858R, and exon 19 deletions. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified leader in oncology innovation, and supplied globally by Onco Solution, this targeted therapy addresses both primary sensitizing […]
Meganor 160 MG (Megestrol Acetate) Tablet
Introduction Meganor 160 mg (Megestrol Acetate) Tablet is a synthetic progestational agent used for the palliative treatment of advanced breast cancer and endometrial carcinoma, as well as managing anorexia and cachexia in patients with AIDS or cancer. Manufactured by Eskayef Pharmaceuticals Ltd., a WHO-GMP-certified pharmaceutical leader, and supplied globally by Onco Solution, this therapy addresses critical needs in oncology and supportive care. […]
Abeclib 150 mg (Abemaciclib) Tablets
Introduction: Abeclib 150 mg, featuring Abemaciclib and produced by Eskayef Pharmaceuticals Ltd., emerges as an innovative therapy in oncology. This medication ushers in a new era of cancer treatment, offering hope and enhanced outcomes for patients afflicted with various cancer types. Description and Usage: Abeclib 150 mg incorporates Abemaciclib, a cyclin-dependent kinases 4 and 6 […]
